Global Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Animal Type(Food-producing animals, Companion animals), By End-use(Veterinary hospitals, Reference laboratories, In-house/point-of-care laboratories.), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2188 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 75

Veterinary Infectious Disease Diagnostics Market Insights

Veterinary Infectious Disease Diagnostics Market size was valued at USD 1.80 Billion in 2021 and is poised to grow from USD 1.96 Billion in 2022 to USD 3.88 Billion by 2030, at a CAGR of 8.9% during the forecast period (2023-2030).

The primary purpose of the veterinary infectious disease diagnostics market is to facilitate the timely and effective diagnosis of infectious diseases in animals. By providing accurate diagnostic solutions, this market aids in the prevention, control, and treatment of infectious diseases, ultimately leading to improved animal health outcomes. Additionally, it helps in the surveillance and monitoring of disease outbreaks, contributing to the overall public health and safety. One of the driving factors for the growth of the veterinary infectious disease diagnostics market is the increasing prevalence of infectious diseases in animals. Factors such as globalization, climate change, and changes in animal husbandry practices have contributed to the spread of infectious diseases, necessitating the need for efficient diagnostic tools. There are also restraining factors that impact the market.

One such factor is the high cost associated with veterinary infectious disease diagnostics, which can limit accessibility, particularly in developing regions. Additionally, the lack of skilled professionals and infrastructure in some areas can hinder the adoption and implementation of diagnostic technologies. The veterinary infectious disease diagnostics market faces several challenges, including the development of diagnostic tools that are both sensitive and specific for a wide range of infectious agents. Keeping up with the constantly evolving nature of infectious diseases and their associated pathogens requires continuous research and development efforts. Nevertheless, there are significant opportunities in the market. Technological advancements, such as the development of rapid and point-of-care diagnostic tests, are expected to enhance the efficiency and accuracy of disease diagnosis.

Furthermore, the growing awareness about zoonotic diseases and the One Health concept, which emphasizes the interconnectedness of human, animal, and environmental health, create opportunities for the expansion of the veterinary infectious disease diagnostics market. the global veterinary infectious disease diagnostics market serves a vital role in animal health and disease management. While it faces challenges and limitations, it also presents opportunities for advancements in diagnostic technologies, ultimately contributing to the overall improvement of animal health and public health worldwide.

US Veterinary Infectious Disease Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Veterinary Infectious Disease Diagnostics Market size was valued at USD 1.80 Billion in 2021 and is poised to grow from USD 1.96 Billion in 2022 to USD 3.88 Billion by 2030, at a CAGR of 8.9% during the forecast period (2023-2030).

The veterinary infectious disease diagnostics market is highly competitive and comprises a diverse range of players, including multinational corporations, regional companies, and niche diagnostic solution providers. The market's competitive landscape is characterized by intense competition, strategic collaborations, product innovations, and mergers and acquisitions. Key players in the market focus on expanding their product portfolios, enhancing their distribution networks, and establishing strong partnerships to strengthen their market presence. Strategic collaborations and partnerships are a common trend in the competitive landscape of the veterinary infectious disease diagnostics market. Companies often collaborate with research institutions, veterinary hospitals, and other industry stakeholders to develop and commercialize innovative diagnostic solutions. These collaborations enable knowledge sharing, access to specialized expertise, and the pooling of resources for research and development initiatives. 'IDEXX Laboratories (US)', 'Zoetis Inc. (US)', 'Thermo Fisher Scientific (US)', 'Heska Corporation (US)', 'Neogen Corporation (US)', 'Virbac (France)', 'Boehringer Ingelheim Animal Health (Germany)', 'Idexx Laboratories Ltd. (UK)', 'Qiagen N.V. (Netherlands)', 'Randox Laboratories Ltd. (UK)', 'Biomerieux SA (France)', 'VCA Inc. (US)', 'Abaxis, Inc. (US)', 'Eurofins Scientific (Luxembourg)', 'GD Animal Health (Netherlands)', 'Mars, Incorporated (US)', 'Fujifilm Holdings Corporation (Japan)', 'Covetrus, Inc. (US)', 'Bioneer Corporation (South Korea)', 'Elanco Animal Health Incorporated (US)'

The growing awareness about animal health and welfare has been a significant driver in the veterinary infectious disease diagnostics market. Pet owners and livestock producers are increasingly seeking advanced diagnostic tools and services to ensure early detection and effective management of infectious diseases. For example, in 2022, the COVID-19 pandemic highlighted the importance of animal health monitoring and the need for robust diagnostic capabilities to identify potential zoonotic diseases.

Point-of-Care Testing: The adoption of point-of-care testing (POCT) in veterinary diagnostics has gained traction as it offers real-time, rapid results without the need for centralized laboratory facilities. POCT devices enable veterinarians to perform diagnostic tests on-site, saving time and allowing for immediate decision-making. This trend has been particularly relevant in 2022, with the development of portable and user-friendly POCT devices for infectious disease diagnosis in animals.

The dominating region in the veterinary infectious disease diagnostics market is North America. This region holds a substantial market share due to several factors that contribute to its dominance. North America boasts a highly developed veterinary healthcare infrastructure, advanced diagnostic technologies, and a strong emphasis on animal health and welfare.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Veterinary Infectious Disease Diagnostics Market

Report ID: SQMIG35D2188

$5,300
BUY NOW GET FREE SAMPLE